Cardiac Positron Emission Tomography (PET)

View Images

Cardiac positron emission tomography (PET) uses radionuclide tracers to evaluate heart tissue functioning. It is especially useful for detecting the type of heart disease that reduces blood flow to the heart muscle. It is specific enough to identify injured, yet living heart muscle.

82 Cardiac Perfusion Imaging is known and recognized as a powerful tool in the assessment of coronary artery disease (CAD). The high sensitivity, specificity and accuracy of cardiac perfusion imaging can potentially reduce the costs associated with CAD by decreasing the need for more expensive and higher risk, invasive procedures.

CardioGen-82 is the only FDA approved generator-based perfusion agent reimbursed for the evaluation of CAD.

Clinical Indications

CAD
Chest Pain
Abnormal EKG
Evaluate PTCA
Dilated Cardiomyopathy
Analysis of Cardiac Symptom Presentations
Chronic Ischemia
Post Myocardial Infarction Syndrome
Hyperlipidemia
Diabetes Mellitus
Persistent symptoms post negative SPECT
Acute and Chronic Vascular Diseases
Myocardial Infarction
Identification of areas at risk of myocardial necrosis when compared with FDG viability study
Surgical Risk Assessment

Technical Advantages of Cardiac PET/CT

Fewer attenuation artifacts
Enhanced spatial resolution
High quality images
Superior resolution
Functional imaging of dynamic processes
In-vivo, non-invasive measurement of coronary floe in m/min/g
Lower radiation exposure

Images